Neuro-Oncology : Impact Factor & More
eISSN: 1523-5866pISSN: 1522-8517
Share this on:
Key Metrics
CiteScore 
18.8
Eigenfactor
0.01 - 0.05
H-Index
150
Impact Factor
15 - 20
Scite Index
0.89 5-Year SI
SJR
Q1Oncology
SNIP
3.17
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Neuro-Oncology
Neuro-Oncology Journal Specifications
Indexed in the following public directories
Web of Science 
Scopus 
SJR
| Overview | |
| Publisher | OXFORD UNIV PRESS INC |
| Language | English |
| Frequency | Monthly |
| General Details | |
| Language | English |
| Frequency | Monthly |
| Publication Start Year | 1999 |
| Publisher URL | Visit website |
| Website URL | Visit website |
View less
Planning to publish in Neuro-Oncology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Neuro-Oncology
Metabolic and Molecular Correlates of Medulloblastoma: Identification of Molecular Groups Using In Vivo 1H-MR Spectroscopy.
- 14 May 2026
- Neuro-oncology
Gods do play dice: The activity of regorafenib in glioblastoma not confirmed.
- 12 May 2026
- Neuro-oncology
Intracranial Progression-Free Survival Correlates with Overall Survival and Varies by Tumor Subtype in Patients with Breast Cancer and Brain Metastases.
- 12 May 2026
- Neuro-oncology
Corrigendum to: Multiomic profiling of glioblastoma metabolic lesions reveals complex intratumoral genomic evolution and dipeptidase-1-driven vascular proliferation.
- 11 May 2026
- Neuro-oncology
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial.
- 10 May 2026
- Neuro-oncology
Association between radiographic response and subsequent recurrence in brain metastases treated with radiation: implications for response assessment criteria.
- 10 May 2026
- Neuro-oncology
Metabolic and Molecular Correlates of Medulloblastoma: Identification of Molecular Groups Using In Vivo 1H-MR Spectroscopy.
- 14 May 2026
- Neuro-oncology
Gods do play dice: The activity of regorafenib in glioblastoma not confirmed.
- 12 May 2026
- Neuro-oncology
Intracranial Progression-Free Survival Correlates with Overall Survival and Varies by Tumor Subtype in Patients with Breast Cancer and Brain Metastases.
- 12 May 2026
- Neuro-oncology
Corrigendum to: Multiomic profiling of glioblastoma metabolic lesions reveals complex intratumoral genomic evolution and dipeptidase-1-driven vascular proliferation.
- 11 May 2026
- Neuro-oncology
Discrepancies in Inter-Rater Agreement on Resectability of Recurrent Glioblastoma: Complementary Post-hoc Analysis of the Prospective, Randomized DIRECTOR Trial.
- 10 May 2026
- Neuro-oncology
Association between radiographic response and subsequent recurrence in brain metastases treated with radiation: implications for response assessment criteria.
- 10 May 2026
- Neuro-oncology
FAQs on Neuro-Oncology
How long has Neuro-Oncology been actively publishing? 
What is the publishing frequency of Neuro-Oncology?
How many articles did Neuro-Oncology publish last year?
What is the eISSN & pISSN for Neuro-Oncology?
What is Citescore for Neuro-Oncology?
What is the H Index for Neuro-Oncology ?
What is SNIP score for Neuro-Oncology?
What is the SJR for Neuro-Oncology?
Who is the publisher of Neuro-Oncology?
